HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Doris Mayr Selected Research
Doris Mayr Research Topics
Disease
101
Neoplasms (Cancer)
11/2023 - 04/2003
42
Breast Neoplasms (Breast Cancer)
09/2023 - 09/2004
36
Ovarian Neoplasms (Ovarian Cancer)
09/2023 - 06/2003
27
Carcinoma (Carcinomatosis)
01/2022 - 06/2003
16
Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2023 - 01/2011
14
Carcinogenesis
09/2023 - 06/2003
13
Endometrial Neoplasms (Endometrial Cancer)
08/2023 - 07/2003
11
Ovarian Epithelial Carcinoma
01/2022 - 10/2012
10
Inflammation (Inflammations)
01/2022 - 06/2003
9
Neoplasm Metastasis (Metastasis)
01/2023 - 06/2011
7
Fibrosis (Cirrhosis)
01/2022 - 03/2007
6
Granulosa Cell Tumor
02/2021 - 01/2008
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2023 - 05/2010
4
Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 03/2016
4
Adenocarcinoma
12/2019 - 06/2003
4
Endometriosis
02/2018 - 11/2012
3
Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 06/2003
3
Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2019 - 07/2007
3
Pancreatic Neoplasms (Pancreatic Cancer)
10/2015 - 08/2011
3
Pre-Eclampsia (Preeclampsia)
09/2008 - 02/2007
3
HELLP Syndrome
09/2008 - 02/2007
2
Disease Progression
10/2023 - 04/2015
2
Rupture
07/2023 - 04/2013
2
Microsatellite Instability
11/2021 - 07/2021
2
Vulvar Neoplasms (Vulvar Cancer)
03/2021 - 12/2020
Drug/Important Bio-Agent (IBA)
33
Proteins (Proteins, Gene)
FDA Link
11/2023 - 07/2006
18
Paraffin
IBA
08/2020 - 09/2004
13
Hormones (Hormone)
IBA
10/2022 - 05/2009
12
Estrogen Receptors
IBA
09/2023 - 11/2012
11
Biomarkers (Surrogate Marker)
IBA
01/2023 - 10/2012
11
Mucin-1 (CA 15-3 Antigen)
IBA
02/2021 - 07/2007
9
Catenins
IBA
01/2023 - 07/2013
8
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 07/2006
8
Formaldehyde (Formol)
FDA Link
07/2020 - 09/2004
7
GTP-Binding Proteins (G-Protein)
IBA
09/2023 - 11/2012
7
Antibodies
IBA
01/2019 - 02/2009
7
Monoclonal Antibodies
IBA
06/2012 - 06/2003
6
Small Interfering RNA (siRNA)
IBA
11/2021 - 03/2013
6
Antigens
IBA
10/2018 - 07/2007
6
Cadherins (E-Cadherin)
IBA
10/2018 - 09/2004
6
Carbohydrates
IBA
01/2018 - 05/2010
5
Enzymes
IBA
11/2021 - 07/2007
5
Galectins (Galectin)
IBA
02/2021 - 05/2012
5
Protein Isoforms (Isoforms)
IBA
01/2021 - 10/2012
5
Ligands
IBA
01/2021 - 10/2015
5
Estrogens (Estrogen)
FDA Link
01/2021 - 09/2008
5
Thyroid Hormone Receptors (Thyroid Hormone Receptor)
IBA
08/2020 - 01/2013
5
Epitopes
IBA
02/2020 - 05/2009
5
Galectin 1 (LGALS1)
IBA
10/2019 - 07/2007
5
Messenger RNA (mRNA)
IBA
01/2019 - 09/2004
5
Oncogene Proteins (Oncogene Protein)
IBA
10/2018 - 03/2009
4
Cytoplasmic and Nuclear Receptors (Nuclear Receptors)
IBA
09/2023 - 10/2012
4
Co-Repressor Proteins
IBA
09/2023 - 01/2019
4
progesterone receptor A
IBA
02/2023 - 11/2007
4
Tumor Biomarkers (Tumor Markers)
IBA
01/2023 - 05/2010
4
Histones (Histone)
IBA
11/2021 - 02/2017
4
Thyroid Hormones
IBA
08/2021 - 10/2012
4
Interleukin-1 (Interleukin 1)
IBA
11/2020 - 08/2014
4
Chemokine CCL22
IBA
12/2019 - 11/2011
4
FSH Receptors (FSH Receptor)
IBA
10/2019 - 01/2013
4
1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)
IBA
06/2017 - 07/2007
4
CA-19-9 Antigen (CA 19-9 Antigen)
IBA
01/2017 - 07/2007
4
Glycodelin
IBA
12/2013 - 02/2009
3
Sirtuin 1
IBA
01/2022 - 08/2020
3
Lysine (L-Lysine)
FDA Link
11/2021 - 03/2020
3
Immune Checkpoint Inhibitors
IBA
11/2021 - 05/2019
3
histone H3 trimethyl Lys4
IBA
11/2021 - 03/2020
3
Bromodeoxyuridine (BrdU)
IBA
03/2021 - 03/2020
3
Vitamin D
FDA Link
Generic
10/2020 - 10/2012
3
Calcitriol Receptors (Calcitriol Receptor)
IBA
10/2020 - 02/2012
3
Indicators and Reagents (Reagents)
IBA
12/2019 - 11/2016
3
Prostaglandins
IBA
10/2019 - 01/2018
3
progesterone receptor B
IBA
01/2019 - 11/2012
3
Carrier Proteins (Binding Protein)
IBA
03/2018 - 06/2017
3
Galectin 3 (LGALS3)
IBA
10/2017 - 02/2011
3
Sialyl Lewis X Antigen
IBA
01/2017 - 07/2007
3
Gonadotropins
IBA
08/2014 - 01/2012
3
Glycoproteins (Glycoprotein)
IBA
07/2013 - 01/2007
3
LH Receptors (LH Receptor)
IBA
01/2013 - 05/2011
3
Peptides (Polypeptides)
IBA
10/2012 - 02/2009
2
Capsules (Microcapsules)
IBA
08/2023 - 07/2023
2
Platelet Activating Factor
IBA
01/2023 - 06/2021
2
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
01/2022 - 02/2018
2
Platinum
IBA
01/2022 - 10/2020
2
Retinoid X Receptors (Retinoid X Receptor)
IBA
01/2022 - 01/2017
2
dostarlimab
IBA
11/2021 - 07/2021
2
pembrolizumab
IBA
11/2021 - 07/2021
2
human ERBB2 protein
IBA
08/2021 - 01/2020
2
RNA (Ribonucleic Acid)
IBA
08/2021 - 03/2013
2
Trace amine-associated receptor 1
IBA
08/2021 - 09/2017
2
Prostaglandin Receptors (Prostaglandin Receptor)
IBA
03/2021 - 01/2018
Therapy/Procedure
34
Therapeutics
09/2023 - 06/2003
9
Drug Therapy (Chemotherapy)
08/2023 - 01/2009
5
Mastectomy (Mammectomy)
01/2016 - 11/2008
4
Immunotherapy
12/2019 - 06/2009
3
Breast Implants (Breast Implant)
08/2023 - 04/2013
3
Radiotherapy
08/2023 - 11/2008
3
Neoadjuvant Therapy
10/2022 - 06/2011
2
Adjuvant Chemotherapy
08/2022 - 06/2011
2
Ligation
01/2021 - 01/2019